Increasing prevalence of neurological/brain disorder like
arteriovenous malformation, epilepsy, rising need for better treatment for rare
disease, increasing investment of biotechnology and pharmaceutical industries
in R&D, and availability of funds drive the growth of the market. Moreover,
increasing government support for research & development, changing
lifestyle, and rapid development in technology will fuel the market growth
during the forecast period. On the other hand, higher cost of the treatment
procedure may slow the market growth during the review period.
Over the last decade, the number of hospitals has increased to a
great extent, which has influenced the growth of the market positively.
Moreover, increasing demand for better treatment and changing reimbursement
policies have fueled the market growth.
The global arteriovenous malformation market is expected to grow
at a CAGR of ~6.1% during the forecast period 2017-2023.
According to the American Stroke Association, AVMs are more
common in males than in females, more than 50% of patients with an AVM have
intracranial hemorrhage and amongst AVM patients, 20%-25% have focal or
generalized seizures.
According to the World Health Organization estimates,
neurological disorders are responsible for 4.5%-11% of all illnesses including
low or high income economies. This is far higher as compared to the number of
respiratory ailments, gastrointestinal disorders, or cancers, and the burden is
expected to increase further over the coming years.
Increasing prevalence of brain diseases/disorders, increasing
investment by biotechnology and pharmaceutical industries in R&D, and
rising need for the better treatment methods drive the growth of the market.
Furthermore, favorable reimbursement policies, increased application and
significant investments in the development of new technologies for the
treatment of diseases will fuel the market growth during the forecast period.
Moreover, globalization in healthcare has increased the market growth.
Established market players in the developed countries leads the globalization
by pushing new products and services into the developing countries and emerging
economies. However, limited availability of facilities and higher treatment
cost may hinder the market growth during the forecast period.
The global arteriovenous malformation market is expected to grow
at a CAGR of ~6.1% during the forecast period 2017-2023.
Key Players
·
Toshiba Medical Systems
Corporation (Japan)
·
Carestream Health (U.S.)
·
Nihon Kohden Corporation
(Japan)
·
Electrical Geodesics Inc.
(U.S.)
·
Fujifilm Holdings (Japan)
·
GE Healthcare (U.S.)
·
Siemens Healthcare(U.S.)
·
Philips Healthcare (U.S.)
·
Shimadzu Corporation (Japan)
·
Masimo Corporation (U.S.)
·
Hologic (U.S.)
·
Esaote (Italy)
Segmentations
The global arteriovenous malformation market is segmented on the
basis of types, diagnosis, treatment, and end user.
On the basis of types it is segmented into true arteriovenous
malformation, occult or cryptic AVM or cavernous malformations, venous
malformation, hemangioma, and dural fistula.
On the basis of diagnosis it is segmented into physical
examination, blood test, brain scans, and others. Brain scan is further
segmented into computerized tomography (CT) scan, magnetic resonance imaging
(MRI), magnetic resonance angiography (MRA), and electroencephalography (EEG).
On the basis of treatment it is segmented into endovascular
embolization, neurosurgery and others.
On the basis of the end user, it is segmented into hospitals
& clinics, research laboratories and others.
Table Of Content
1. Report Prologue
2. Market
Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research
Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor
Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment